imc-3g3, a fully human igg1 monoclonal antibody against pdgfr-α (ImClone Inc)
90
Structured Review
ImClone Inc
imc-3g3, a fully human igg1 monoclonal antibody against pdgfr-α
Imc 3g3, A Fully Human Igg1 Monoclonal Antibody Against Pdgfr α, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imc-3g3+antibody/imc+a12+antibody/us10676527-312-25-36
Average 90 stars, based on 1 article reviews
Imc 3g3, A Fully Human Igg1 Monoclonal Antibody Against Pdgfr α, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imc-3g3+antibody/imc+a12+antibody/us10676527-312-25-36
Average 90 stars, based on 1 article reviews
imc-3g3, a fully human igg1 monoclonal antibody against pdgfr-α - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Blocking Assay:Article Title: Methods and compositions for modulation of blood-neural barrier Article Snippet: Also, numerous anti-PDGFR-α antibodies are available, including anti-human PDGFR-α polyclonal and monoclonal antibodies that can be obtained commercially from R&D Systems, Inc., Minneapolis, Minn., and IMC-3G3, a fully Article Title: Angiogenesis inhibitors for the treatment of ovarian cancer Article Snippet: A total of 110 enrolled patients is aimed for; 25 patients had been enrolled at 6 sites as of January 2010 Interventions Randomisation to either arm A or arm B, continuing until disease progression or other withdrawal criteria: arm A: doxorubicin (40 mg/m2) every 4 weeks Article Title: Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma Article Snippet: IMC-3G3 is a fully Article Title: The α-Receptor for Platelet-Derived Growth Factor Confers Bone-Metastatic Potential to Prostate Cancer Cells by Ligand- and Dimerization-Independent Mechanisms Article Snippet: We thank Dr. Olimpia Meucci (Drexel College of Medicine) for helpful discussion, Dr. Gregg Johannes and Jeff Thomas (Department of Pathology, Drexel College of Medicine) for help with the Article Title: THE ALPHA RECEPTOR FOR PLATELET DERIVED GROWTH FACTOR CONFERS BONE-METASTATIC POTENTIAL TO PROSTATE CANCER CELLS BY LIGAND- AND DIMERIZATION-INDEPENDENT MECHANISMS Article Snippet: The authors wish to thank Dr. Olimpia Meucci (Drexel College of Medicine) for helpful discussion, Dr. Gregg Johannes and Article Title: Methods and compositions for modulation of blood-neural barrier Article Snippet: Also, numerous anti-PDGFR-α antibodies are available, including anti-human PDGFR-α polyclonal and monoclonal antibodies that can be obtained commercially from R&D Systems, Inc., Minneapolis, Minn., and IMC-3G3, a fully Article Title: Ligand-Independent Activation of Platelet-Derived Growth Factor Receptor β during Human Immunodeficiency Virus–Transactivator of Transcription and Cocaine-Mediated Smooth Muscle Hyperplasia Article Snippet: Monoclonal IMC-3G3 antibody was kindly provided by Dr. Nick Loizos, Article Title: Monoclonal Antibodies for the Treatment of Cancer Article Snippet: Activation Assay:Article Title: Methods and compositions for modulation of blood-neural barrier Article Snippet: Also, numerous anti-PDGFR-α antibodies are available, including anti-human PDGFR-α polyclonal and monoclonal antibodies that can be obtained commercially from R&D Systems, Inc., Minneapolis, Minn., and IMC-3G3, a fully Article Title: Angiogenesis inhibitors for the treatment of ovarian cancer Article Snippet: A total of 110 enrolled patients is aimed for; 25 patients had been enrolled at 6 sites as of January 2010 Interventions Randomisation to either arm A or arm B, continuing until disease progression or other withdrawal criteria: arm A: doxorubicin (40 mg/m2) every 4 weeks Article Title: Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma Article Snippet: IMC-3G3 is a fully Article Title: The α-Receptor for Platelet-Derived Growth Factor Confers Bone-Metastatic Potential to Prostate Cancer Cells by Ligand- and Dimerization-Independent Mechanisms Article Snippet: We thank Dr. Olimpia Meucci (Drexel College of Medicine) for helpful discussion, Dr. Gregg Johannes and Jeff Thomas (Department of Pathology, Drexel College of Medicine) for help with the Article Title: THE ALPHA RECEPTOR FOR PLATELET DERIVED GROWTH FACTOR CONFERS BONE-METASTATIC POTENTIAL TO PROSTATE CANCER CELLS BY LIGAND- AND DIMERIZATION-INDEPENDENT MECHANISMS Article Snippet: The authors wish to thank Dr. Olimpia Meucci (Drexel College of Medicine) for helpful discussion, Dr. Gregg Johannes and Article Title: Methods and compositions for modulation of blood-neural barrier Article Snippet: Also, numerous anti-PDGFR-α antibodies are available, including anti-human PDGFR-α polyclonal and monoclonal antibodies that can be obtained commercially from R&D Systems, Inc., Minneapolis, Minn., and IMC-3G3, a fully Article Title: Ligand-Independent Activation of Platelet-Derived Growth Factor Receptor β during Human Immunodeficiency Virus–Transactivator of Transcription and Cocaine-Mediated Smooth Muscle Hyperplasia Article Snippet: Monoclonal IMC-3G3 antibody was kindly provided by Dr. Nick Loizos, Article Title: Monoclonal Antibodies for the Treatment of Cancer Article Snippet: Expressing:Article Title: Methods and compositions for modulation of blood-neural barrier Article Snippet: Also, numerous anti-PDGFR-α antibodies are available, including anti-human PDGFR-α polyclonal and monoclonal antibodies that can be obtained commercially from R&D Systems, Inc., Minneapolis, Minn., and IMC-3G3, a fully Article Title: Angiogenesis inhibitors for the treatment of ovarian cancer Article Snippet: A total of 110 enrolled patients is aimed for; 25 patients had been enrolled at 6 sites as of January 2010 Interventions Randomisation to either arm A or arm B, continuing until disease progression or other withdrawal criteria: arm A: doxorubicin (40 mg/m2) every 4 weeks Article Title: Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma Article Snippet: IMC-3G3 is a fully Article Title: The α-Receptor for Platelet-Derived Growth Factor Confers Bone-Metastatic Potential to Prostate Cancer Cells by Ligand- and Dimerization-Independent Mechanisms Article Snippet: We thank Dr. Olimpia Meucci (Drexel College of Medicine) for helpful discussion, Dr. Gregg Johannes and Jeff Thomas (Department of Pathology, Drexel College of Medicine) for help with the Article Title: THE ALPHA RECEPTOR FOR PLATELET DERIVED GROWTH FACTOR CONFERS BONE-METASTATIC POTENTIAL TO PROSTATE CANCER CELLS BY LIGAND- AND DIMERIZATION-INDEPENDENT MECHANISMS Article Snippet: The authors wish to thank Dr. Olimpia Meucci (Drexel College of Medicine) for helpful discussion, Dr. Gregg Johannes and Article Title: Methods and compositions for modulation of blood-neural barrier Article Snippet: Also, numerous anti-PDGFR-α antibodies are available, including anti-human PDGFR-α polyclonal and monoclonal antibodies that can be obtained commercially from R&D Systems, Inc., Minneapolis, Minn., and IMC-3G3, a fully Article Title: Ligand-Independent Activation of Platelet-Derived Growth Factor Receptor β during Human Immunodeficiency Virus–Transactivator of Transcription and Cocaine-Mediated Smooth Muscle Hyperplasia Article Snippet: Monoclonal IMC-3G3 antibody was kindly provided by Dr. Nick Loizos, Article Title: Monoclonal Antibodies for the Treatment of Cancer Article Snippet: Plasmid Preparation:Article Title: Methods and compositions for modulation of blood-neural barrier Article Snippet: Also, numerous anti-PDGFR-α antibodies are available, including anti-human PDGFR-α polyclonal and monoclonal antibodies that can be obtained commercially from R&D Systems, Inc., Minneapolis, Minn., and IMC-3G3, a fully Article Title: Angiogenesis inhibitors for the treatment of ovarian cancer Article Snippet: A total of 110 enrolled patients is aimed for; 25 patients had been enrolled at 6 sites as of January 2010 Interventions Randomisation to either arm A or arm B, continuing until disease progression or other withdrawal criteria: arm A: doxorubicin (40 mg/m2) every 4 weeks Article Title: Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma Article Snippet: IMC-3G3 is a fully Article Title: The α-Receptor for Platelet-Derived Growth Factor Confers Bone-Metastatic Potential to Prostate Cancer Cells by Ligand- and Dimerization-Independent Mechanisms Article Snippet: We thank Dr. Olimpia Meucci (Drexel College of Medicine) for helpful discussion, Dr. Gregg Johannes and Jeff Thomas (Department of Pathology, Drexel College of Medicine) for help with the Article Title: THE ALPHA RECEPTOR FOR PLATELET DERIVED GROWTH FACTOR CONFERS BONE-METASTATIC POTENTIAL TO PROSTATE CANCER CELLS BY LIGAND- AND DIMERIZATION-INDEPENDENT MECHANISMS Article Snippet: The authors wish to thank Dr. Olimpia Meucci (Drexel College of Medicine) for helpful discussion, Dr. Gregg Johannes and Article Title: Methods and compositions for modulation of blood-neural barrier Article Snippet: Also, numerous anti-PDGFR-α antibodies are available, including anti-human PDGFR-α polyclonal and monoclonal antibodies that can be obtained commercially from R&D Systems, Inc., Minneapolis, Minn., and IMC-3G3, a fully Article Title: Ligand-Independent Activation of Platelet-Derived Growth Factor Receptor β during Human Immunodeficiency Virus–Transactivator of Transcription and Cocaine-Mediated Smooth Muscle Hyperplasia Article Snippet: Monoclonal IMC-3G3 antibody was kindly provided by Dr. Nick Loizos, Article Title: Monoclonal Antibodies for the Treatment of Cancer Article Snippet: |
